The Journal of Molecular Diagnostics: Machine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and Identify Therapeutic Candidates

This study aims to identify RNA biomarkers distinguishing neuromyelitis optica (NMO) from relapsing-remitting multiple sclerosis (RRMS) and explore potential therapeutic applications leveraging machine learning. Read the full publication at www.jmdjournal.org

This study aims to identify RNA biomarkers distinguishing neuromyelitis optica (NMO) from relapsing-remitting multiple sclerosis (RRMS) and explore potential therapeutic applications leveraging machine learning.

Read the full publication at www.jmdjournal.org

Date Posted:

June 7, 2024

Share This:

High Alpha Blog GraphicAI in Pharma: Revolutionizing Biotechnology and Precision Medicine
The Power of Public Genomics Databases in Biomarker Discovery